Near-infrared autofluorescence: Its relationship to short-wavelength autofluorescence and optical coherence tomography in recessive stargardt disease

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 5, 2015, Pages 3226-3234

  Greenstein, Vivienne C ^a   Schuman, Ari D ^a   Lee, Winston ^a   Duncker, Tobias ^a,b   Zernant, Jana ^a   Allikmets, Rando ^a,c   Hood, Donald C ^a   Sparrow, Janet R ^a,c  

^a Columbia University ^*  (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Department of Medicine   (United States)

Author keywords

ABCA4; Fundus autofluorescence; Optical coherence tomography; Recessive stargardt disease; Retinal pigment epithelium

Indexed keywords

ABC TRANSPORTER; ABCA4 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; CENTRAL MACULAR THICKNESS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MALE; NEAR INFRARED IMAGING SYSTEM; NEXT GENERATION SEQUENCING; PHOTORECEPTOR INNER SEGMENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FOVEA; RETINA ROD OUTER SEGMENT; RETINAL NERVE FIBER LAYER THICKNESS; SCANNING LASER OPHTHALMOSCOPY; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STARGARDT DISEASE; YOUNG ADULT; FLUORESCENCE ANGIOGRAPHY; MACULAR DEGENERATION; NEAR INFRARED SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; RETINA MACULA LUTEA;

ADOLESCENT; ADULT; CHILD; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; SPECTROSCOPY, NEAR-INFRARED; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84939838756     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-16050     Document Type: Article

References (29)

1. Allikmets R, Singh N, Sun H, et al. A photoreceptor cellspecific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15: 236–246.
2. Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110:1151–1158.
3. Armstrong JD, Meyer D, Xu S, Elfervig JL. Long-term follow-up of Stargardt’s disease and fundus flavimaculatus. Ophthalmology. 1998;105:448–457.
4. Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in patients with Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–814.
5. von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol. 1997;115:609–615.
6. Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW. Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol. 2004;138:55–63.
7. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest Ophthalmol Vis Sci. 2006;47:3556–3564.
8. Kellner S, Kellner U, Weber BH, Fiebig B, Weinitz S, Ruether K. Lipofuscin- and melanin-related fundus autofluorescence in patients with ABCA4-associated retinal dystrophies. Am J Ophthalmol. 2009;147:895–902.
9. Duncker T, Marsiglia M, Lee W, et al. Correlations among nearinfrared and short-wavelength autofluorescence and spectral domain optical coherence tomography in recessive Stargardt disease. Invest Ophthalmol Vis Sci. 2014;55:8134–8143.
10. Ergun E, Hermann B, Wirtitsch M, et al. Assessment of central visual function in Stargardt’s disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:310–316.
11. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with highspeed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:2054.1–14.
12. Burke TR, Rhee DW, Smith RT, et al. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). Invest Ophthalmol Vis Sci. 2011;52:8006–8015.
13. Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69–77.
14. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119:359–369.
15. Zernant J, Schubert C, Im KM, et al. Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci. 2011;52:8479–8487.
16. Delori F, Greenberg JP, Woods RL, et al. Quantitative measurements of autofluorescence with the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci. 2011;52:9379–9390.
17. Yang Q, Reisman CA, Chan K, Ramachandran R, Raza A, Hood DC. Automated segmentation of outer retinal layers in macular OCT images of patients with retinitis pigmentosa. Biomed Opt Express. 2011;2:2493–2503.
18. Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt’s disease–Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1995;36:2327–2331.
19. Chun R, Fishman GA, Collison FT, Stone EM, Zernant J, Allikmets R. The value of retinal imaging with infrared scanning laser ophthalmoscopy in patients with stargardt disease. Retina. 2014;34:1391–1399.
20. Schmitz-Valckenberg S, Lara D, Nizari S, et al. Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging. Br J Ophthalmol. 2011;95:1134–1139.
21. Cukras CA, Wong WT, Caruso R, Cunningham D, Zein W, Sieving PA. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol. 2012;130:171–179.
22. Gibbs D, Cideciyan AV, Jacobson SG, Williams DS. Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence. Invest Ophthalmol Vis Sci. 2009;50:4386–4393.
23. Rudolf M, Vogt SD, Curcio CA, et al. Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology. 2013;120:821–828.
24. Burke TR, Duncker T, Woods RL, et al. Quantitative fundus autofluorescence in recessive Stargardt disease. Invest Ophthalmol Vis Sci. 2014;55:2841–2852.
25. Gelman R, Chen R, Blonska A, Barile G, Sparrow JR. Fundus autofluorescence imaging in a patient with rapidly developing scotoma. Retin Cases Brief Reps. 2012;6:345–348.
26. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525–534.
27. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50:3953–3959.
28. Ritter M, Zotter S, Schmidt WM, Bittner RE, Deak GG, et al. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging. Invest Ophthalmol Vis Sci. 2013;54:6416–6425.
29. Sayegh RG, Simader C, Scheschy U, et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. Ophthalmology. 2011;118:1844–1851.